Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.86 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | CA12 | O43570 | 2/20 | 0.68 |
| ▸ | CA1 | P00915 | 2/20 | 0.68 |
| ▸ | CA2 | P00918 | 2/20 | 0.68 |
| ▸ | CA7 | P43166 | 2/20 | 0.68 |
| ▸ | CA9 | Q16790 | 2/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.68 |
| ▸ | CA4 | P22748 | 1/20 | 0.68 |
| ▸ | CA6 | P23280 | 1/20 | 0.68 |
| ▸ | TPMT | P51580 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Veratric Acid Methyl Ester SCHEMBL29573244 | 1.00 | MAPT (0.86) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| Veratric Acid Methyl Ester SCHEMBL22717084 | 0.93 | MAPT (0.75) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| Veratric Acid Methyl Ester SCHEMBL3661352 | 0.91 | MAPT (0.73) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| SCHEMBL4529606 | 0.89 | CYP1A2 (0.79) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| Veratric Acid Methyl Ester SCHEMBL2371276 | 0.89 | MAPT (0.70) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| SCHEMBL23480903 | 0.89 | MAPT (0.70) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| SCHEMBL12554591 | 0.89 | MAPT (0.70) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| SCHEMBL13963809 | 0.88 | KMT2A (0.80) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| SCHEMBL3193863 | 0.88 | TSHR (0.70) | MAPTTSHRCYP2C9CYP1A2CYP3A4 | |
| SCHEMBL8778631 | 0.88 | TSHR (0.70) | MAPTTSHRCYP2C9CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504444-A | Preparation method of 5-nitrovanillic acid | 浙江工业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-112334131-B | Pharmaceutical composition comprising indirubin derivative as active ingredient | CK生物技术公司 | 2024-04-05 | — | — | CN | claimed |
| CN-115558089-B | Electronic-ion mixed conductive polymer, preparation method and application thereof in preparation of high-magnification water-based zinc ion battery | 吉林大学 | 2024-02-02 | — | — | CN | claimed |
| CN-116804657-A | Identification method of various anti-hair loss chemical drugs in cosmetics | 重庆海关技术中心 | 2023-09-26 | — | — | CN | claimed |
| CN-113046179-B | Dendrobium officinale flower fragrance composition and preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-06-06 | — | — | CN | claimed |
| CN-115558089-A | Electron-ion mixed conductive polymer, preparation method and application thereof in preparation of high-rate water-based zinc ion battery | 吉林大学 | 2023-01-03 | — | — | CN | claimed |
| CN-115141334-A | Sulfur-containing bio-based benzoxazine resin and preparation method thereof | 中北大学 | 2022-10-04 | — | — | CN | claimed |
| CN-114292192-A | Synthesis method of 3, 4-dimethoxybenzoic acid methyl ester | 山东泓瑞医药科技股份公司 | 2022-04-08 | — | — | CN | claimed |
| CN-110093064-B | Preparation method and application of long-afterglow luminescent ink | 重庆理工大学 | 2021-07-13 | — | — | CN | claimed |
| CN-109715220-A | Oil agent and lubricating oil for odor conversion | 山本香料株式会社 | 2019-05-03 | — | — | CN | claimed |
| CN-109689117-A | Foul smell method of converting | 山本香料株式会社 | 2019-04-26 | — | — | CN | claimed |
| CN-109248707-A | It is a kind of acidity mesopore molecular sieve preparation method and its application in catalytic esterification | 青岛科技大学 | 2019-01-22 | — | — | CN | claimed |
| CN-107260816-B | A kind of pharmaceutical composition with antidepression effect and preparation method thereof | 黑龙江中医药大学 | 2018-03-27 | — | — | CN | claimed |
| CN-104849379-B | Method for measuring tanshinol, meta-methyl tanshinol, protocatechualdehyde and protocatechuic acid in human plasma | 天士力制药集团股份有限公司 | 2017-10-31 | — | — | CN | claimed |
| CN-107260816-A | A kind of pharmaceutical composition with antidepression effect and preparation method thereof | 黑龙江中医药大学 | 2017-10-20 | — | — | CN | claimed |
| CN-106889311-A | Mixed feed prepared by a kind of use shrimping beam trawl | 浙江海洋大学 | 2017-06-27 | — | — | CN | claimed |
| CN-103319704-B | Method for preparing polyester through using 10-hendecenoic acid and vanillic acid | UNIV NANKAI | 2015-06-17 | — | — | CN | claimed |
| CN-103467726-A | Preparation method for degradable polyester from 10-undecenoic acid and vanillic acid | UNIV NANKAI | 2013-12-25 | — | — | CN | claimed |
| CN-103319704-A | Method for preparing polyester through using 10-hendecenoic acid and vanillic acid | UNIV NANKAI | 2013-09-25 | — | — | CN | claimed |
| US-12576662-B2 | Thermographic imaging element | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| CN-121653048-A | Method for inducing and differentiating fibroblast into vascular endothelial cell | 海南博鳌未来医院有限公司 | 2026-03-13 | — | — | CN | disclosed |
| US-20250382290-A1 | SALTS OF SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250312504-A1 | VOLATILE COMPOSITION DISPENSER FOR COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | THE PROCTER & GAMBLE COMPANY | 2025-10-09 | — | — | US | disclosed |
| CN-120741684-A | Gout wet syndrome biomarker, diagnosis/prediction model and construction method thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2025-10-03 | — | — | CN | disclosed |
| US-20250270220-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250270210-A1 | BCL-2 Inhibitor | BEIGENE, LTD. (KY) | 2025-08-28 | — | — | US | disclosed |
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | LINTFIELD LIMITED (GB) | 2025-08-26 | — | — | US | disclosed |
| CN-120098190-A | Macroporous resin material and preparation method thereof | 北华大学 | 2025-06-06 | — | — | CN | disclosed |
| US-12304915-B2 | SOS1 inhibitors | Mirati Therapeutics, Inc. (US) | 2025-05-20 | — | — | US | disclosed |
| CN-120004738-A | Octyl vanillate and preparation method and application thereof | 广东电网有限责任公司电力科学研究院 | 2025-05-16 | — | — | CN | disclosed |
| EP-4543450-A1 | SALTS OF SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-12286430-B2 | Bcl-2 inhibitor | BEIGENE, LTD. (KY) | 2025-04-29 | — | — | US | disclosed |
| EP-3668863-B1 | TRICYCLIC COMPOUNDS AS HISTONE METHYL-TRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119504444-A | Preparation method of 5-nitrovanillic acid | 浙江工业大学 | 2025-02-25 | — | — | CN | disclosed |
| US-20250059182-A1 | SOS1 INHIBITORS | MIRATI THERAPEUTICS, INC | 2025-02-20 | — | — | US | disclosed |
| CN-119322135-A | Method for detecting traditional Chinese medicine source components in pinecone extract | 大理大学 | 2025-01-17 | — | — | CN | disclosed |
| CN-119192970-A | Water-resistant high-adhesion two-component waterborne polyurethane coating and preparation method thereof | 上海巴世夫化工涂料有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119192970-A | Water-resistant high-adhesion two-component waterborne polyurethane coating and preparation method thereof | 上海巴世夫化工涂料有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20240376097-A1 | BCL-2 Inhibitor | BEIGENE LTD. (KY) | 2024-11-14 | — | — | US | disclosed |
| CN-116333314-B | Method for preparing degradable polyester based on solvent-free polymerization of 10-undecylenic acid | 华南理工大学 | 2024-11-05 | — | — | CN | disclosed |
| CN-114805201-B | Preparation method and application of 2-N-morpholinoethoxy group substituted quinoline derivative | 陕西蒲城万德科技有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118591547-A | Method for obtaining antioxidant composition from lignin, lignin liquor or black liquor | 塞内尔基金会 | 2024-09-03 | — | — | CN | disclosed |
| CN-118234793-A | Stabilizer based on syringic acid, vanillic acid, isovanillic acid or 5-hydroxyveratric acid, plastic composition, method for stabilizing a plastic composition and stabilizer composition | 弗劳恩霍夫应用研究促进协会 | 2024-06-21 | — | — | CN | disclosed |
| CN-118221722-A | Aromatic bio-based flame retardant plasticizer with different alkyl chain lengths, and preparation method and application thereof | 安徽大学 | 2024-06-21 | — | — | CN | disclosed |
| US-20240199997-A1 | COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | PROCTER & GAMBLE COMPANY, THE | 2024-06-20 | — | — | US | disclosed |
| CN-116391718-B | Liquid sterilization preparation containing enestroburin and application thereof | 沈阳中化农药化工研发有限公司 | 2024-06-11 | — | — | CN | disclosed |
| EP-4359219-A1 | THERMOGRAPHIC IMAGING ELEMENT | International Imaging Materials Inc. (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117836596-A | Temperature indicator manufacturing system and temperature indicator manufacturing method | 株式会社日立产机系统 | 2024-04-05 | — | — | CN | disclosed |
| CN-112334131-B | Pharmaceutical composition comprising indirubin derivative as active ingredient | CK生物技术公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-112334131-B | Pharmaceutical composition comprising indirubin derivative as active ingredient | CK生物技术公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20240094619-A1 | THERMOGRAPHIC IMAGING ELEMENT | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2024-03-21 | — | — | US | disclosed |
| CN-112500413-B | Xanthine aromatic acid ether derivatives, preparation method and application thereof | 安徽中医药大学 | 2024-03-01 | — | — | CN | disclosed |
| CN-117502459-A | Bactericidal composition containing bacillus tertiarygensis and synergistic combination bactericide and application thereof | 河北省农林科学院植物保护研究所 | 2024-02-06 | — | — | CN | disclosed |
| CN-115558089-B | Electronic-ion mixed conductive polymer, preparation method and application thereof in preparation of high-magnification water-based zinc ion battery | 吉林大学 | 2024-02-02 | — | — | CN | disclosed |
| CN-117426473-A | Preparation method of salix mongolica water extract, preparation method of salix mongolica flavor seasoning and application of salix mongolica flavor seasoning | 黄山学院 | 2024-01-23 | — | — | CN | disclosed |
| CN-116987667-B | Method for differentiating pluripotent stem cells into macrophages or neutrophils | 天海元祺生物科技(天津)有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-111655681-B | Heterocyclylamino-substituted triazoles as modulators of Rho-related protein kinases | 莱德克斯制药公共有限公司 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023250165-A1 | SALTS OF SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2023-12-28 | — | — | WO | disclosed |
| CN-117017966-A | Application of dimethyl itaconate in inhibiting escherichia coli and salmonella | 浙江大学 | 2023-11-10 | — | — | CN | disclosed |
| US-11807628-B2 | Benzodiazepine derivatives and uses thereof | INTOCELL, INC. (KR) | 2023-11-07 | — | — | US | disclosed |
| CN-116987667-A | Method for differentiating pluripotent stem cells into macrophages or neutrophils | 天海元祺生物科技(天津)有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116969936-A | BCL-2 inhibitors | 百济神州有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116969937-A | BCL-2 inhibitors | 百济神州有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116869989-A | Application of itaconic acid in inhibiting escherichia coli and salmonella | 浙江大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-116804657-A | Identification method of various anti-hair loss chemical drugs in cosmetics | 重庆海关技术中心 | 2023-09-26 | — | — | CN | disclosed |
| CN-116804657-A | Identification method of various anti-hair loss chemical drugs in cosmetics | 重庆海关技术中心 | 2023-09-26 | — | — | CN | disclosed |
| CN-116802179-A | BCL-2 inhibitors | 百济神州有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-113244942-B | Nonmetallic nitrogen-doped porous carbon catalyst and method for preparing carboxylic acid methyl ester compound | 辽宁师范大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-111542736-B | Temperature detecting material and estimation system for temperature deviation time using the same | 株式会社日立产机系统 | 2023-08-29 | — | — | CN | disclosed |
| CN-113461640-B | LPAR1 inhibitor, medical application and preparation method thereof | 中央民族大学 | 2023-08-11 | — | — | CN | disclosed |
| US-11717573-B2 | Methods and compositions for the treatment of cancer | SOUTH DAKOTA BOARD OF REGENTS (US) | 2023-08-08 | — | — | US | disclosed |
| CN-113072602-B | Phenolic acid glycosyl ester and preparation method thereof | 广东省科学院化工研究所 | 2023-08-01 | — | — | CN | disclosed |
| US-11702418-B2 | SOS1 inhibitors | Mirati Therapeutics, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
| CN-116391718-A | Liquid sterilization preparation containing enestroburin and application thereof | 沈阳中化农药化工研发有限公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-116333314-A | Method for preparing degradable polyester based on solvent-free polymerization of 10-undecylenic acid | 华南理工大学 | 2023-06-27 | — | — | CN | disclosed |
| CN-111566103-B | Aminoimidazopyrazines as kinase inhibitors | 百时美施贵宝公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-22 | — | — | US | disclosed |
| CN-113046179-B | Dendrobium officinale flower fragrance composition and preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-06-06 | — | — | CN | disclosed |
| US-11661410-B2 | Tricyclic compounds as histone methyltransferase inhibitors | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2023-05-30 | — | — | US | disclosed |
| US-20230159522-A1 | BCL-2 INHIBITOR | BEONE MEDICINES I GMBH (CH) | 2023-05-25 | — | — | US | disclosed |
| CN-111093620-B | Composition for preventing hair loss or promoting hair growth | CK雷容股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-111620764-B | Selective ether bond cleavage method of aryl alkyl ether | 荆楚理工学院 | 2023-05-05 | — | — | CN | disclosed |
| US-20230137886-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. | 2023-05-04 | — | — | US | disclosed |
| US-20230137886-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. | 2023-05-04 | — | — | US | disclosed |
| CN-115844013-A | Method for improving stability of procyanidine in lycium ruthenicum murr | 合肥工业大学 | 2023-03-28 | — | — | CN | disclosed |
| WO-2023280317-A1 | BENZYLAMINO TRICYCLIC COMPOUND AND USE THEREOF | 南京明德新药研发有限公司 | 2023-01-12 | — | — | WO | disclosed |
| CN-112898355-B | Method for preventing lignin degradation intermediate product from polycondensation | 北华大学 | 2023-01-06 | — | — | CN | disclosed |
| US-20230002351-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-01-05 | — | — | US | disclosed |
| CN-115558089-A | Electron-ion mixed conductive polymer, preparation method and application thereof in preparation of high-rate water-based zinc ion battery | 吉林大学 | 2023-01-03 | — | — | CN | disclosed |
| WO-2022271595-A1 | THERMOGRAPHIC IMAGING ELEMENT | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2022-12-29 | — | — | WO | disclosed |
| US-20220396581-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. (US) | 2022-12-15 | — | — | US | disclosed |
| CN-115448780-A | Composite resistance inducer and method for preventing and controlling southern root-knot nematodes of kiwi fruits step by step | 贵州省山地资源研究所 | 2022-12-09 | — | — | CN | disclosed |
| CN-114714723-B | Polypropylene type recyclable packaging film and preparation method thereof | 惠州市道科包装材料有限公司 | 2022-11-22 | — | — | CN | disclosed |
| EP-4076418-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2022-10-26 | — | — | EP | disclosed |
| CN-115141334-A | Sulfur-containing bio-based benzoxazine resin and preparation method thereof | 中北大学 | 2022-10-04 | — | — | CN | disclosed |
| CN-115135315-A | SOS1 inhibitors | 米拉蒂治疗股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-11385542-B2 | Salt, quencher, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-07-12 | — | — | US | disclosed |
| CN-114714723-A | Polypropylene type recyclable packaging film and preparation method thereof | 惠州市道科包装材料有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220169581-A1 | DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2022-06-02 | — | — | US | disclosed |
| CN-114292192-A | Synthesis method of 3, 4-dimethoxybenzoic acid methyl ester | 山东泓瑞医药科技股份公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114292192-A | Synthesis method of 3, 4-dimethoxybenzoic acid methyl ester | 山东泓瑞医药科技股份公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114292192-A | Synthesis method of 3, 4-dimethoxybenzoic acid methyl ester | 山东泓瑞医药科技股份公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-113957741-A | Titanium composite material and application thereof in preparation of base paper | 浙江科技学院 | 2022-01-21 | — | — | CN | disclosed |
| CN-109824513-B | Method for preparing carboxylic ester by direct alcohol oxidation esterification method | 中国科学院大连化学物理研究所 | 2021-11-26 | — | — | CN | disclosed |
| US-20210277017-A1 | Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition | LINTFIELD LIMITED (GB) | 2021-09-09 | — | — | US | disclosed |
| US-20210277017-A1 | Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition | LINTFIELD LIMITED (GB) | 2021-09-09 | — | — | US | disclosed |
| CN-113244942-A | Non-metal nitrogen-doped porous carbon catalyst and method for preparing methyl carboxylate compound | 辽宁师范大学 | 2021-08-13 | — | — | CN | disclosed |
| CN-108947783-B | Method for catalyzing oxidative degradation of lignin into aromatic monomer by molybdenum | 中国科学院大连化学物理研究所 | 2021-08-03 | — | — | CN | disclosed |
| CN-108947784-B | Method for catalyzing oxidative degradation of lignin into aromatic monomer by manganese | 中国科学院大连化学物理研究所 | 2021-08-03 | — | — | CN | disclosed |
| CN-110093064-B | Preparation method and application of long-afterglow luminescent ink | 重庆理工大学 | 2021-07-13 | — | — | CN | disclosed |
| US-20210188857-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. | 2021-06-24 | — | — | US | disclosed |
| US-20210188857-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. | 2021-06-24 | — | — | US | disclosed |
| WO-2021127429-A1 | SOS1 INHIBITORS | Mirati Therapeutics, Inc. (US) | 2021-06-24 | — | — | WO | disclosed |
| CN-112969965-A | Thioxanthone derivative, composition comprising the same, and pattern forming method comprising the composition | 林特弗德有限公司 | 2021-06-15 | — | — | CN | disclosed |
| CN-112898355-A | Method for preventing lignin degradation intermediate product from polycondensation | 北华大学 | 2021-06-04 | — | — | CN | disclosed |
| EP-3824349-A1 | THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION | Lintfield Limited (GB) | 2021-05-26 | — | — | EP | disclosed |
| US-11014935-B2 | Compounds for the treatment of paramyxovirus viral infections | Janssen Biopharma, Inc. (US) | 2021-05-25 | — | — | US | disclosed |
| US-10966987-B2 | Therapeutic compounds and uses thereof | KALA PHARMACEUTICALS, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-20210063874-A1 | SALT, QUENCHER, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-03-04 | — | — | US | disclosed |
| EP-3109703-B1 | PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, AND METHOD FOR FORMING PATTERN USING SAME | TOKYO ELECTRON LTD (JP) | 2020-12-30 | — | — | EP | disclosed |
| CN-108144612-B | Cobalt-based catalyst for synthesizing carboxylic ester by one-pot method and preparation and application thereof | 中国科学院大连化学物理研究所 | 2020-12-29 | — | — | CN | disclosed |
| CN-110054613-B | Substituted aminoquinazoline compound, pharmaceutical composition and application thereof | 深圳市塔吉瑞生物医药有限公司 | 2020-11-27 | — | — | CN | disclosed |
| WO-2020232375-A1 | OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE | SILICON SWAT, INC. (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-3718545-A1 | ANTITUMOR AGENT | Taiho Pharmaceutical Co., Ltd. (JP) | 2020-10-07 | — | — | EP | disclosed |
| CN-111372927-A | Tricyclic compounds as histone methyltransferase inhibitors | 全球血液疗法股份有限公司 | 2020-07-03 | — | — | CN | disclosed |
| EP-3668863-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYL-TRANSFERASE INHIBITORS | Global Blood Therapeutics, Inc. (US) | 2020-06-24 | — | — | EP | disclosed |
| US-10689577-B2 | Bondable flame-retardant vanillin-derived molecules | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-06-23 | — | — | US | disclosed |
| US-10689578-B2 | Flame-retardant vanillin-derived cross-linkers | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-06-23 | — | — | US | disclosed |
| US-10689579-B2 | Flame-retardant vanillin-derived small molecules | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-06-23 | — | — | US | disclosed |
| US-20200159116-A1 | SALT, QUENCHER, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-21 | — | — | US | disclosed |
| CN-107118128-B | Preparation method of 3, 4-dihydroxy benzonitrile | 常州佳德医药科技有限公司 | 2020-04-21 | — | — | CN | disclosed |
| US-20200054644-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | KALA BIO, Inc. | 2020-02-20 | — | — | US | disclosed |
| WO-2020016389-A1 | THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION | LINTFIELD LIMITED (GB) | 2020-01-23 | — | — | WO | disclosed |
| WO-2020016389-A1 | THIOXANTHONE DERIVATIVES, COMPOSITION COMPRISING THE SAME AND PATTERN FORMING METHOD COMPRISING SAID COMPOSITION | LINTFIELD LIMITED (GB) | 2020-01-23 | — | — | WO | disclosed |
| CN-105085429-B | Aromatic heterocyclic derivative and application thereof in medicines | 广东东阳光药业有限公司 | 2019-12-10 | — | — | CN | disclosed |
| CN-110016016-A | Benzimidazole carboxylic acid fragment and preparation method thereof in a kind of GSK484 | 绍兴文理学院 | 2019-07-16 | — | — | CN | disclosed |
| US-20190177619-A1 | FLAME-RETARDANT VANILLIN-DERIVED SMALL MOLECULES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-06-13 | — | — | US | disclosed |
| US-20190136137-A1 | FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-05-09 | — | — | US | disclosed |
| US-10266771-B2 | Bondable flame-retardant vanillin-derived molecules | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2019-04-23 | — | — | US | disclosed |
| US-20190106632-A1 | BONDABLE FLAME-RETARDANT VANILLIN-DERIVED MOLECULES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-04-11 | — | — | US | disclosed |
| WO-2019046778-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF | MAVUPHARMA, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| WO-2019036377-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYL-TRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2019-02-21 | — | — | WO | disclosed |
| CN-109225314-A | A kind of application for the method and acid mesopore molecular sieve preparing acid mesopore molecular sieve using sodium peroxydisulfate | 青岛科技大学 | 2019-01-18 | — | — | CN | disclosed |
| US-10023512-B2 | Production of organic materials using oxidative hydrothermal dissolution method | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) | 2018-07-17 | — | — | US | disclosed |
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | TOKYO ELECTRON LIMITED (JP) | 2018-07-17 | — | — | US | disclosed |
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | TOKYO ELECTRON LIMITED (JP) | 2018-07-17 | — | — | US | disclosed |
| US-20180194893-A1 | Method of Preparing Hyperbranched Polyether Ester | JIANGNAN UNIVERSITY (CN) | 2018-07-12 | — | — | US | disclosed |
| US-20180194893-A1 | Method of Preparing Hyperbranched Polyether Ester | JIANGNAN UNIVERSITY (CN) | 2018-07-12 | — | — | US | disclosed |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | JSR CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | JSR CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-9971247-B2 | Pattern-forming method | OSAKA UNIVERSITY (JP) | 2018-05-15 | — | — | US | disclosed |
| US-9971247-B2 | Pattern-forming method | OSAKA UNIVERSITY (JP) | 2018-05-15 | — | — | US | disclosed |
| CN-107260816-B | A kind of pharmaceutical composition with antidepression effect and preparation method thereof | 黑龙江中医药大学 | 2018-03-27 | — | — | CN | disclosed |
| US-20180002298-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PROTAMED INC (US) | 2018-01-04 | — | — | US | disclosed |
| CN-104040032-B | Paint-on technique improves | 庄信万丰股份有限公司 | 2017-12-22 | — | — | CN | disclosed |
| US-20170355997-A1 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-12-14 | — | — | US | disclosed |
| CN-104849379-B | Method for measuring tanshinol, meta-methyl tanshinol, protocatechualdehyde and protocatechuic acid in human plasma | 天士力制药集团股份有限公司 | 2017-10-31 | — | — | CN | disclosed |
| CN-104849379-B | Method for measuring tanshinol, meta-methyl tanshinol, protocatechualdehyde and protocatechuic acid in human plasma | 天士力制药集团股份有限公司 | 2017-10-31 | — | — | CN | disclosed |
| CN-107260816-A | A kind of pharmaceutical composition with antidepression effect and preparation method thereof | 黑龙江中医药大学 | 2017-10-20 | — | — | CN | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-9771592-B2 | Methods and compositions for treating or preventing pruritis | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-09-26 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| CN-106889311-A | Mixed feed prepared by a kind of use shrimping beam trawl | 浙江海洋大学 | 2017-06-27 | — | — | CN | disclosed |
| US-20170131633-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170131633-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170075221-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-20170075221-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| CN-101978042-B | Methods and organisms for utilizing syngas or other gaseous carbon sources and methanol | 基因组股份公司 | 2017-03-08 | — | — | CN | disclosed |
| US-20170052450-A1 | PATTERN-FORMING METHOD | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170052449-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170052450-A1 | PATTERN-FORMING METHOD | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170052449-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170052448-A1 | RESIST-PATTERN-FORMING METHOD AND CHEMICALLY AMPLIFIED RESIST MATERIAL | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170052448-A1 | RESIST-PATTERN-FORMING METHOD AND CHEMICALLY AMPLIFIED RESIST MATERIAL | OSAKA UNIVERSITY (JP) | 2017-02-23 | — | — | US | disclosed |
| EP-3133445-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL | OSAKA UNIVERSITY (JP) | 2017-02-22 | — | — | EP | disclosed |
| EP-3133444-A1 | CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND | OSAKA UNIVERSITY (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-20170022174-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PROTAMED INC (US) | 2017-01-26 | — | — | US | disclosed |
| US-20170022174-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PROTAMED INC (US) | 2017-01-26 | — | — | US | disclosed |
| US-20160357103-A1 | PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, METHOD FOR FORMING PATTERN USING SAME, SEMICONDUCTOR DEVICE, MASK FOR LITHOGRAPHY, AND TEMPLATE FOR NANOIMPRINTING | TOKYO ELECTRON LIMITED (JP) | 2016-12-08 | — | — | US | disclosed |
| US-20160357103-A1 | PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, METHOD FOR FORMING PATTERN USING SAME, SEMICONDUCTOR DEVICE, MASK FOR LITHOGRAPHY, AND TEMPLATE FOR NANOIMPRINTING | TOKYO ELECTRON LIMITED (JP) | 2016-12-08 | — | — | US | disclosed |
| WO-2016079759-A1 | NOVEL SINGLE STEP ESTERIFICATION PROCESS OF ALDEHYDES USING A HETEROGENEOUS CATALYST | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-05-26 | — | — | WO | disclosed |
| US-9334251-B2 | Compounds for the treatment of neurodegenerative diseases | PROTAMED, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9334251-B2 | Compounds for the treatment of neurodegenerative diseases | PROTAMED, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9169260-B2 | Amidopyrazole inhibitors of interleukin receptor-associated kinases | MERCK SHARP & DOHME CORP. (US) | 2015-10-27 | — | — | US | disclosed |
| US-20150274681-A1 | Compounds for the treatment of Neurodegenerative Diseases | PROTEOTECH INC. (US) | 2015-10-01 | — | — | US | disclosed |
| US-20150274681-A1 | Compounds for the treatment of Neurodegenerative Diseases | PROTEOTECH INC. (US) | 2015-10-01 | — | — | US | disclosed |
| US-9133137-B2 | Derivatives of gefitinib | CONCERT PHARMACEUTICALS, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-9133137-B2 | Derivatives of gefitinib | CONCERT PHARMACEUTICALS, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| CN-103467726-B | The method of degradable polyester is prepared based on Shiyixisuan Undecylenic Acid and vanillic acid | NANKAI UNIVERSITY (CN) | 2015-09-09 | — | — | CN | disclosed |
| US-20150238498-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2015-08-27 | — | — | US | disclosed |
| US-9085549-B2 | Compounds for the treatment of neurodegenerative diseases | PROTEOTECH INC (US) | 2015-07-21 | — | — | US | disclosed |
| US-9085549-B2 | Compounds for the treatment of neurodegenerative diseases | PROTEOTECH INC (US) | 2015-07-21 | — | — | US | disclosed |
| EP-2888240-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | Alios Biopharma, Inc. (US) | 2015-07-01 | — | — | EP | disclosed |
| CN-104736530-A | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA INC | 2015-06-24 | — | — | CN | disclosed |
| CN-103319704-B | Method for preparing polyester through using 10-hendecenoic acid and vanillic acid | UNIV NANKAI | 2015-06-17 | — | — | CN | disclosed |
| US-20150011604-A1 | Compounds for the treatment of neurodegenerative diseases | PROTEOTECH INC. (US) | 2015-01-08 | — | — | US | disclosed |
| US-20150011604-A1 | Compounds for the treatment of neurodegenerative diseases | PROTEOTECH INC. (US) | 2015-01-08 | — | — | US | disclosed |
| US-8865754-B2 | Compounds for the treatment of neurodegenerative diseases | PROTEOTECH INC. (US) | 2014-10-21 | — | — | US | disclosed |
| US-8865754-B2 | Compounds for the treatment of neurodegenerative diseases | PROTEOTECH INC. (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140303231-A1 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-10-09 | — | — | US | disclosed |
| CN-104040032-A | Improvements in coating technology | JOHNSON MATTHEY PLC | 2014-09-10 | — | — | CN | disclosed |
| US-8809432-B2 | Reusable print medium and method of manufacturing thereof | OCE TECHNOLOGIES B.V. (NL) | 2014-08-19 | — | — | US | disclosed |
| US-20140194404-A1 | AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES | MERCK SHARP & DOHME LLC | 2014-07-10 | — | — | US | disclosed |
| WO-2014031784-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | ALIOS BIOPHARMA, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031784-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | ALIOS BIOPHARMA, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| EP-2688872-A1 | AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES | Merck Sharp & Dohme Corp. (US) | 2014-01-29 | — | — | EP | disclosed |
| CN-103492618-A | Improvements in coating technology | JOHNSON MATTHEY PLC | 2014-01-01 | — | — | CN | disclosed |
| CN-103467726-A | Preparation method for degradable polyester from 10-undecenoic acid and vanillic acid | UNIV NANKAI | 2013-12-25 | — | — | CN | disclosed |
| US-20130338202-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PROTEO TECH, INC (US) | 2013-12-19 | — | — | US | disclosed |
| WO-2012167252-A9 | PRODUCTION OF ORGANIC MATERIALS USING AN OXIDATIVE HYDROTHERMAL DISSOLUTION METHOD | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) | 2013-12-05 | — | — | WO | disclosed |
| CN-103319704-A | Method for preparing polyester through using 10-hendecenoic acid and vanillic acid | UNIV NANKAI | 2013-09-25 | — | — | CN | disclosed |
| EP-2242493-B1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC (US) | 2013-06-05 | — | — | EP | disclosed |
| EP-2242493-B1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC (US) | 2013-06-05 | — | — | EP | disclosed |
| US-20130137805-A1 | REUSABLE PRINT MEDIUM AND METHOD OF MANUFACTURING THEREOF | OCE TECHNOLOGIES B.V. (NL) | 2013-05-30 | — | — | US | disclosed |
| WO-2012167252-A1 | PRODUCTION OF ORGANIC MATERIALS USING AN OXIDATIVE HYDROTHERMAL DISSOLUTION METHOD | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) | 2012-12-06 | — | — | WO | disclosed |
| US-20120289695-A1 | PRODUCTION OF ORGANIC MATERIALS USING OXIDATIVE HYDROTHERMAL DISSOLUTION METHOD | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) | 2012-11-15 | — | — | US | disclosed |
| CN-102746242-A | Synthesis method of 6, 7-substituent-4-aniline quinazoline | OMEGA CO LTD | 2012-10-24 | — | — | CN | disclosed |
| US-20120251448-A1 | Compounds for Use in the Detection of Neurodegenerative Diseases | AVID RADIOPHARMACEUTICALS, INC. | 2012-10-04 | — | — | US | disclosed |
| US-20120251448-A1 | Compounds for Use in the Detection of Neurodegenerative Diseases | AVID RADIOPHARMACEUTICALS, INC. | 2012-10-04 | — | — | US | disclosed |
| WO-2012129258-A1 | AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES | MERCK SHARP & DOHME CORP. (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012118935-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PROTEOTECH INC (US) | 2012-09-07 | — | — | WO | disclosed |
| CN-1984883-B | Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies | PROTEOTECH INC | 2012-03-21 | — | — | CN | disclosed |
| US-8084464-B2 | Tetrahydroisoquinoline derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084464-B2 | Tetrahydroisoquinoline derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084464-B2 | Tetrahydroisoquinoline derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| CN-101792416-B | Process for preparing bosutinib | UNIV NANJING MEDICAL | 2011-10-05 | — | — | CN | disclosed |
| US-7964531-B2 | 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20110130375-A1 | NEW NO-RELEASING STEROIDS FOR THE TREATMENT OF RETINA AND MACULA LUTEA DISEASES | NICOX S.A. (FR) | 2011-06-02 | — | — | US | disclosed |
| US-20110130376-A1 | NEW NO RELEASING STEROIDS DERIVATIVES | NICOX S.A. (FR) | 2011-06-02 | — | — | US | disclosed |
| US-20110059046-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2011-03-10 | — | — | US | disclosed |
| US-20110059046-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2011-03-10 | — | — | US | disclosed |
| US-7855204-B2 | Derivatives of gefitinib | CONCERT PHARMACEUTICALS INC. (US) | 2010-12-21 | — | — | US | disclosed |
| US-7855204-B2 | Derivatives of gefitinib | CONCERT PHARMACEUTICALS INC. (US) | 2010-12-21 | — | — | US | disclosed |
| US-7855204-B2 | Derivatives of gefitinib | CONCERT PHARMACEUTICALS INC. (US) | 2010-12-21 | — | — | US | disclosed |
| EP-2242493-A1 | DERIVATIVES OF GEFITINIB | Concert Pharmaceuticals Inc. (US) | 2010-10-27 | — | — | EP | disclosed |
| US-20100267949-A1 | Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline | OMEGA MEDICAL TAIWAN LIMITED (TW) | 2010-10-21 | — | — | US | disclosed |
| EP-2231155-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | Concert Pharmaceuticals Inc. (US) | 2010-09-29 | — | — | EP | disclosed |
| CN-101792416-A | Process for preparing bosutinib | UNIV NANJING MEDICAL | 2010-08-04 | — | — | CN | disclosed |
| CN-101680167-A | Method for the breakdown of lignin | ETH ZUERICH | 2010-03-24 | — | — | CN | disclosed |
| US-20100041555-A1 | 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same | MITSUI CHEMICALS AGRO, INC. (JP) | 2010-02-18 | — | — | US | disclosed |
| US-7608563-B2 | 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same | MITSUI AGRO CHEMICALS, INC. (JP) | 2009-10-27 | — | — | US | disclosed |
| EP-1426365-B9 | 3-PHENOXY-4-PYRIDAZINOL DERIVATIVE AND HERBICIDE COMPOSITION CONTAINING THE SAME | MITSUI CHEMICALS AGRO INC (JP) | 2009-10-21 | — | — | EP | disclosed |
| WO-2009094216-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-30 | — | — | WO | disclosed |
| WO-2009094216-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-30 | — | — | WO | disclosed |
| US-20090192188-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2009-07-30 | — | — | US | disclosed |
| US-20090192188-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2009-07-30 | — | — | US | disclosed |
| US-20090192188-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2009-07-30 | — | — | US | disclosed |
| US-20090185999-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-23 | — | — | US | disclosed |
| US-20090185999-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-23 | — | — | US | disclosed |
| US-20090185999-A1 | DERIVATIVES OF GEFITINIB | CONCERT PHARMACEUTICALS INC. (US) | 2009-07-23 | — | — | US | disclosed |
| EP-1426365-B1 | 3-PHENOXY-4-PYRIDAZINOL DERIVATIVE AND HERBICIDE COMPOSITION CONTAINING THE SAME | SANKYO AGRO CO LTD (JP) | 2009-07-15 | — | — | EP | disclosed |
| WO-2009079637-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009079637-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2009-06-25 | — | — | WO | disclosed |
| EP-2049117-A2 | PREPARATION AND UTILITY OF SUBSTITUTED QUINAZOLINE COMPOUNDS WITH ALPHA-ADRENERGIC BLOCKING EFFECTS | Auspex Pharmaceuticals Inc. (US) | 2009-04-22 | — | — | EP | disclosed |
| CN-101200736-A | Method for preparing vanillic acid methyl esters | SONG ZHENGYU (CN) | 2008-06-18 | — | — | CN | disclosed |
| CN-101200736-A | Method for preparing vanillic acid methyl esters | SONG ZHENGYU (CN) | 2008-06-18 | — | — | CN | disclosed |
| US-20080124569-A1 | Electroluminescent Complexes | OLED-T LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| US-20080124569-A1 | Electroluminescent Complexes | OLED-T LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| US-20080124569-A1 | Electroluminescent Complexes | OLED-T LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| WO-2008021891-A2 | PREPARATION AND UTILITY OF SUBSTITUTED QUINAZOLINE COMPOUNDS WITH ALPHA-ADRENERGIC BLOCKING EFFECTS | AUSPEX PHARMACEUTICALS, INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20080039473-A1 | PREPARATION AND UTILITY OF SUBSTITUTED QUINAZOLINE COMPOUNDS WITH ALPHA-ADRENERGIC BLOCKING EFFECTS | AUSPEX PHARMACEUTICALS, INC. (US) | 2008-02-14 | — | — | US | disclosed |
| CN-101090899-A | 2,5 and 2,6 disubstituted benzazole analogs useful as protein kinase inhibitors | 4SC AG (DE) | 2007-12-19 | — | — | CN | disclosed |
| CN-1984883-A | Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies | PROTEOTECH INC (US) | 2007-06-20 | — | — | CN | disclosed |
| WO-2006048679-A2 | ELECTROLUMINESCENT COMPLEXES | OLED-T LIMITED (GB) | 2006-05-11 | — | — | WO | disclosed |
| EP-1575890-A1 | PROCESS FOR THE PREPARATION OF 3- 2-(3,4-DIMETHOXY-BENZOYL)- 4,5-DIMETHOXY-PHENYL -PENTAN-2-ONE | EGIS GYOGYSZERGYAR RT. (HU) | 2005-09-21 | — | — | EP | disclosed |
| US-20050037925-A1 | 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same | SANKYO AGRO COMPANY, LIMITED (JP) | 2005-02-17 | — | — | US | disclosed |
| US-6790977-B2 | REACTING THE 3,4-DIALKOXY BENZONITRILE WITH AN ALKALI METAL HALIDE, FOLLOWED BY TREATING WITH HYDROCHLORIC ACID; HIGH YIELD AND A LOW COST STARTING MATERIAL | SINON CORPORATION (TW) | 2004-09-14 | — | — | US | disclosed |
| WO-2004054951-A1 | PROCESS FOR THE PREPARATION OF 3-[2-(3,4-DIMETHOXY-BENZOYL)-4,5-DIMETHOXY-PHENYL]-PENTAN-2-ONE | EGIS GYOGYSZERGYAR RT. (HU) | 2004-07-01 | — | — | WO | disclosed |
| WO-2004054952-A1 | PROCESS FOR THE PREPARATION OF 3-[2-(3,4-DIMETHOXYBENZOYL)-4,5- DIMETHOXYPHENYL] -PENTAN-2-ONE | EGIS GYOGYSZERGYAR RT. (HU) | 2004-07-01 | — | — | WO | disclosed |
| EP-1426365-A1 | 3-PHENOXY-4-PYRIDAZINOL DERIVATIVE AND HERBICIDE COMPOSITION CONTAINING THE SAME | Sankyo Agro Company, Limited (JP) | 2004-06-09 | — | — | EP | disclosed |
| EP-0945440-B1 | AMINOPYRAZOLE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-20040024239-A1 | Process for preparing 3,4-dihydroxy-benzonitrile | SINON CORPORATION (TW) | 2004-02-05 | — | — | US | disclosed |
| EP-0955293-B1 | UREA DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2003-03-19 | — | — | EP | disclosed |
| EP-0945438-B1 | PYRAZOLE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2003-03-05 | — | — | EP | disclosed |
| US-6384045-B1 | TREATMENT OF ALZHEIMER'S DISEASE AND ANTICANCER AGENTS | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2002-05-07 | — | — | US | disclosed |
| EP-0885184-B1 | PERFLUORO(ALKOXYCYCLOALKANE)CARBONYL FLUORIDE COMPOSITIONS AND THEIR USE | MINNESOTA MINING & MFG (US) | 2002-04-24 | — | — | EP | disclosed |
| US-6245779-B1 | ANALGESICS; ANTIINFLAMMATORY AGENTS | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2001-06-12 | — | — | US | disclosed |
| US-6180653-B1 | EATING DISORDERS; DIETETICS; ANTIDIABETIC AGENTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2001-01-30 | — | — | US | disclosed |
| US-6110976-A | AS CHEMICAL INTERMEDIATES FOR PREPARING SURFACTATNTS, IN AQUEOUS FILM-FORMING FOAM SOLUTIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-08-29 | — | — | US | disclosed |
| EP-0997463-A1 | NAPHTHYRIDINE DERIVATIVES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2000-05-03 | — | — | EP | disclosed |
| US-6057335-A | Pyrazole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-05-02 | — | — | US | disclosed |
| US-6043246-A | Urea derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-03-28 | — | — | US | disclosed |
| EP-0955293-A1 | NOVEL UREA DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-11-10 | — | — | EP | disclosed |
| EP-0945440-A1 | AMINOPYRAZOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |
| EP-0945438-A1 | PYRAZOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |
| US-5958970-A | ENZYME INHIBITORS OF ACETYLCHOLINESTERASE (ACHE) AND ACYL-COA:CHOLESTEROL ACYLTRANSFERASE (ACAT); USED IN THE TREATMENT OF ALZHEIMER'S DISEASE, ATHEROSCLEROSIS AND HYPERCHOLESTEROLEMIA | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1999-09-28 | — | — | US | disclosed |
| EP-0885184-A1 | PERFLUORO(ALKOXYCYCLOALKANE)CARBONYL FLUORIDE COMPOSITIONS AND THEIR USE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-12-23 | — | — | EP | disclosed |
| WO-1998039010-A1 | TRICYCLIC AND TETRACYCLIC PYRONES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-09-11 | — | — | WO | disclosed |
| US-5760025-A | ADMINISTERING TESTOSTERONE 5A-REDUCTASE INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1998-06-02 | — | — | US | disclosed |
| US-5756000-A | WATER SOLUBLE, FLUORINE-FREE SURFACTANTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-26 | — | — | US | disclosed |
| US-5717088-A | REACTING WITH A CYANOPHOSPHATE IN THE PRESENCE OF AN ALKALI METAL CYANIDE | SANKYO COMPANY, LIMITED (JP) | 1998-02-10 | — | — | US | disclosed |
| US-5698720-A | INTERMEDIATES FOR TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1997-12-16 | — | — | US | disclosed |
| WO-1997029070-A1 | PERFLUORO(ALKOXYCYCLOALKANE)CARBONYL FLUORIDE COMPOSITIONS AND THEIR USE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-08-14 | — | — | WO | disclosed |
| EP-0567271-B1 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO CO (JP) | 1997-07-02 | — | — | EP | disclosed |
| EP-0725074-A2 | Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives | SANKYO COMPANY LIMITED (JP) | 1996-08-07 | — | — | EP | disclosed |
| US-5536714-A | Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-16 | — | — | US | disclosed |
| US-RE34630-E | Antagonist for platelet activating factor | EUROCELTIQUE, S.A. (LU) | 1994-06-07 | — | — | US | disclosed |
| US-5191121-A | Sunscreen | KAO CORPORATION (JP) | 1993-03-02 | — | — | US | disclosed |
| US-5146002-A | Sunscreen | KAO CORPORATION (JP) | 1992-09-08 | — | — | US | disclosed |
| EP-0422328-A2 | Substituted isoquinolines and their use | Euro-Celtique S.A. (LU) | 1991-04-17 | — | — | EP | disclosed |
| EP-0416564-A2 | Novel aroyl ketone derivative, UV ray absorber comprising the same, and cosmetic composition containing the same | KAO CORPORATION (JP) | 1991-03-13 | — | — | EP | disclosed |
| US-4956371-A | PLATELET ACTIVATING FACTOR | EUROCELTIQUE, S.A. (LU) | 1990-09-11 | — | — | US | disclosed |
| EP-0148883-B1 | ALLOPURINOL PRODRUGS | A/S GEA Farmaceutisk Fabrik (DK) | 1990-02-14 | — | — | EP | disclosed |
| US-4760174-A | Tetralin derivatives, their preparation and their use | BASF AKTIENGESELLSCHAFT (DE) | 1988-07-26 | — | — | US | disclosed |
| US-4694006-A | Acyl- or acyloxymethyl-allopurinol prodrugs | A/S GEA (DK) | 1987-09-15 | — | — | US | disclosed |
| EP-0148883-A1 | ALLOPURINOL PRODRUGS. | GEA AS (DK) | 1985-07-24 | — | — | EP | disclosed |
| WO-1985000368-A1 | ALLOPURINOL PRODRUGS | A/S GEA (DK) | 1985-01-31 | — | — | WO | disclosed |
| US-4453004-A | Process for the alkylation of phenolic compounds | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4453017-A | ETHERS FROM PHENOLIC ALDEHYDES, ACIDS, OR AMIDES | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4453018-A | ONE-STEP PREPARATION OF ALKYLATED PHENOLIC ETHERS | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4342875-A | STABILIZERS FOR OLEFIN POLYMERS | CINCINNATI-MILACRON, INC. (US) | 1982-08-03 | — | — | US | disclosed |
| US-4279982-A | PRINTOUTS; OXADIAZOLE PHOTOINITIATORS | FUJI PHOTO FILM CO., LTD. (JP) | 1981-07-21 | — | — | US | disclosed |
| US-3976780-A | Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES L'ILE-DE-FRANCE (FR) | 1976-08-24 | — | — | US | disclosed |
| US-3954748-A | ANTIEMETICS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1976-05-04 | — | — | US | disclosed |
| US-3954748-A | ANTIEMETICS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | CD47, ENPP2, CD2 | MAPT 1430/4885TSHR 823/4885CYP2C9 4247/4885 |
| US-20210063874-A1 | SALT, QUENCHER, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SLC11A2, AFF1, NHERF1 | MAPT 4640/4885TSHR 130/4885CYP2C9 2084/4885 |
| US-20150238498-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | SARS1, MAVS, ZC3HAV1 | MAPT 4529/4885TSHR 4302/4885CYP2C9 4712/4885 |
| US-20110130376-A1 | NEW NO RELEASING STEROIDS DERIVATIVES | CYP11B2, CYP11B1, NR3C2 | MAPT 3867/4885TSHR 421/4885CYP2C9 262/4885 |
| US-20090192188-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | HCRTR2, HCRTR1, OXTR | MAPT 885/4885TSHR 932/4885CYP2C9 2014/4885 |
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | ASIC1, ASIC3, CLTA | MAPT 2727/4885TSHR 4284/4885CYP2C9 1859/4885 |
| US-11807628-B2 | Benzodiazepine derivatives and uses thereof | GABRB3, GABRB2, GABRB1 | MAPT 1303/4885TSHR 1282/4885CYP2C9 786/4885 |
| US-20220396581-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | MAVS, SARS1, ZC3HAV1 | MAPT 4377/4885TSHR 4424/4885CYP2C9 4825/4885 |
| US-11014935-B2 | Compounds for the treatment of paramyxovirus viral infections | MAVS, SARS1, ZC3HAV1 | MAPT 4377/4885TSHR 4424/4885CYP2C9 4825/4885 |
| US-20150274681-A1 | Compounds for the treatment of Neurodegenerative Diseases | PSEN1, PSEN2, GRN | MAPT 4/4885TSHR 4355/4885CYP2C9 4881/4885 |
| US-20120289695-A1 | PRODUCTION OF ORGANIC MATERIALS USING OXIDATIVE HYDROTHERMAL DISSOLUTION METHOD | HAO2, HPD, AOC2 | MAPT 747/4885TSHR 4625/4885CYP2C9 49/4885 |
| US-20250270210-A1 | BCL-2 Inhibitor | BCL2, BCL2A1, BCL2L1 | MAPT 2558/4885TSHR 4278/4885CYP2C9 3172/4885 |
| US-20230002351-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | EHMT1, EHMT2, BMI1 | MAPT 2437/4885TSHR 3593/4885CYP2C9 4233/4885 |
| US-20180002298-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PSEN1, PSEN2, GRN | MAPT 4/4885TSHR 4355/4885CYP2C9 4881/4885 |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | MAVS, SARS1, ZC3HAV1 | MAPT 4377/4885TSHR 4424/4885CYP2C9 4825/4885 |
| US-20220169581-A1 | DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST | PPOX, CYCS, SCO2 | MAPT 3090/4885TSHR 2838/4885CYP2C9 282/4885 |
| US-10966987-B2 | Therapeutic compounds and uses thereof | MUC1, CFTR, SLC26A4 | MAPT 1508/4885TSHR 3465/4885CYP2C9 336/4885 |
| US-20170355997-A1 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS | ITCH, CCL11, CPA3 | MAPT 1265/4885TSHR 4595/4885CYP2C9 4302/4885 |
| US-20110130375-A1 | NEW NO-RELEASING STEROIDS FOR THE TREATMENT OF RETINA AND MACULA LUTEA DISEASES | LHCGR, NR5A1, LSS | MAPT 3021/4885TSHR 345/4885CYP2C9 4261/4885 |
| US-20150011604-A1 | Compounds for the treatment of neurodegenerative diseases | SNCA, MAPT, PARK7 | MAPT 2/4885TSHR 4107/4885CYP2C9 4798/4885 |
| US-20200159116-A1 | SALT, QUENCHER, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SLC11A2, MSR1, NHERF1 | MAPT 4611/4885TSHR 211/4885CYP2C9 1860/4885 |
| US-11385542-B2 | Salt, quencher, resist composition and method for producing resist pattern | SLC11A2, MSR1, NHERF1 | MAPT 4611/4885TSHR 211/4885CYP2C9 1860/4885 |
| US-20190177619-A1 | FLAME-RETARDANT VANILLIN-DERIVED SMALL MOLECULES | PFAS, PTK2, VCL | MAPT 1313/4885TSHR 2282/4885CYP2C9 3251/4885 |
| US-20090185999-A1 | DERIVATIVES OF GEFITINIB | ABL1, EGFR, ERBB2 | MAPT 4547/4885TSHR 1339/4885CYP2C9 2670/4885 |
| US-20250382290-A1 | SALTS OF SOS1 INHIBITORS | SOS1, SOS2, SOST | MAPT 3589/4885TSHR 3559/4885CYP2C9 4483/4885 |
| US-11717573-B2 | Methods and compositions for the treatment of cancer | HUNK, VIM, PBK | MAPT 2415/4885TSHR 4188/4885CYP2C9 1567/4885 |
| US-10689577-B2 | Bondable flame-retardant vanillin-derived molecules | PFAS, VCL, PTK2 | MAPT 1269/4885TSHR 2152/4885CYP2C9 2400/4885 |
| US-20100267949-A1 | Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline | NQO2, ATIC, CYP3A7 | MAPT 3826/4885TSHR 3494/4885CYP2C9 18/4885 |
| US-20120251448-A1 | Compounds for Use in the Detection of Neurodegenerative Diseases | SNCA, PARK7, NLN | MAPT 15/4885TSHR 4503/4885CYP2C9 4866/4885 |
| US-11661410-B2 | Tricyclic compounds as histone methyltransferase inhibitors | EHMT1, EHMT2, BMI1 | MAPT 2437/4885TSHR 3593/4885CYP2C9 4233/4885 |
| US-12304915-B2 | SOS1 inhibitors | SOS1, SOS2, SAV1 | MAPT 3786/4885TSHR 3357/4885CYP2C9 4835/4885 |
| US-20190136137-A1 | FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS | PFAS, VCL, PFKFB2 | MAPT 1654/4885TSHR 2306/4885CYP2C9 1647/4885 |
| US-20250059182-A1 | SOS1 INHIBITORS | SOS1, SOS2, SOST | MAPT 3961/4885TSHR 3618/4885CYP2C9 4799/4885 |
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | TPMT, TST, PPOX | MAPT 410/4885TSHR 1691/4885CYP2C9 252/4885 |
| US-20230159522-A1 | BCL-2 INHIBITOR | BCL2, BCL2A1, BCL2L1 | MAPT 2558/4885TSHR 4278/4885CYP2C9 3172/4885 |
| US-10023512-B2 | Production of organic materials using oxidative hydrothermal dissolution method | HAO2, HPD, AOC2 | MAPT 747/4885TSHR 4625/4885CYP2C9 49/4885 |
| US-20200054644-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | MUC1, CFTR, SLC26A4 | MAPT 1508/4885TSHR 3465/4885CYP2C9 336/4885 |
| US-20230137886-A1 | SOS1 INHIBITORS | SOS1, SOS2, SAV1 | MAPT 3786/4885TSHR 3357/4885CYP2C9 4835/4885 |
| US-20140303231-A1 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS | ITCH, CCL11, CPA3 | MAPT 1265/4885TSHR 4595/4885CYP2C9 4302/4885 |
| US-20100041555-A1 | 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same | CBR3, DDT, CBR1 | MAPT 4175/4885TSHR 603/4885CYP2C9 54/4885 |
| US-20140194404-A1 | AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES | IRAK4, IRAK3, IRAK1 | MAPT 3202/4885TSHR 1009/4885CYP2C9 3807/4885 |
| US-20240376097-A1 | BCL-2 Inhibitor | BCL2, BCL2A1, BCL2L1 | MAPT 2558/4885TSHR 4278/4885CYP2C9 3172/4885 |
| US-20190106632-A1 | BONDABLE FLAME-RETARDANT VANILLIN-DERIVED MOLECULES | PFAS, VCL, PTK2 | MAPT 1269/4885TSHR 2152/4885CYP2C9 2400/4885 |
| US-20080039473-A1 | PREPARATION AND UTILITY OF SUBSTITUTED QUINAZOLINE COMPOUNDS WITH ALPHA-ADRENERGIC BLOCKING EFFECTS | ADRB1, ADRB2, ADRB3 | MAPT 2648/4885TSHR 756/4885CYP2C9 254/4885 |
| US-20250270220-A1 | SOS1 INHIBITORS | SOS1, SOS2, SAV1 | MAPT 3786/4885TSHR 3357/4885CYP2C9 4835/4885 |
| US-20040024239-A1 | Process for preparing 3,4-dihydroxy-benzonitrile | PAH, HCN4, HPD | MAPT 2879/4885TSHR 3671/4885CYP2C9 468/4885 |
| US-10689579-B2 | Flame-retardant vanillin-derived small molecules | PFAS, PTK2, VCL | MAPT 1313/4885TSHR 2282/4885CYP2C9 3251/4885 |
| US-20170022174-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PSEN1, PSEN2, GRN | MAPT 4/4885TSHR 4355/4885CYP2C9 4881/4885 |
| US-10689578-B2 | Flame-retardant vanillin-derived cross-linkers | PFAS, VCL, PFKFB2 | MAPT 1654/4885TSHR 2306/4885CYP2C9 1647/4885 |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | SLC11A2, XRCC5, RAD54L | MAPT 3421/4885TSHR 2793/4885CYP2C9 4342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.